Send the following on WhatsApp
Continue to Chathttps://es.marketscreener.com/cotizacion/accion/REGENERON-PHARMACEUTICALS-10649/noticia/El-beneficio-del-segundo-trimestre-de-Teva-Pharm-supera-las-previsiones-y-reafirma-las-perspectivas-31060680/?utm_source=whatsapp&utm_medium=social&utm_campaign=share